Stock FURIEX PHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Furiex Pharmaceuticals Inc

Equities

US36106P1012

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Furiex Pharmaceuticals Inc
2014 Actavis : Factbox - M&A frenzy transforming global pharma RE
2014 Actavis : M&A frenzy in healthcare sector RE

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Furiex Pharmaceuticals : Actavis Completes Acquisition of Furiex Pharmaceuticals
PR
Furiex Pharmaceuticals : Stockholders Approve Acquisition by Actavis; Ukrainian Antimonopoly Committee Clears Proposed Merger
BU
Furiex Pharmaceuticals : Reports First Quarter 2014 Financial Results
BU
Actavis : Factbox - M&A frenzy transforming global pharma
RE
Actavis : M&A frenzy in healthcare sector
RE
Furiex Pharmaceuticals : Ryan & Maniskas, LLP : Announces Investigation of Furiex Pharmaceuticals, Inc.
PR
Furiex Pharmaceuticals : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Furiex Pharmaceuticals, Inc. Stockholders
BU
Furiex Pharmaceuticals : Stockholders Encouraged to Contact Securities Law Firm about Takeover
PR
Furiex Pharmaceuticals : Newman Ferrara LLP : Announces Investigation of Furiex Pharmaceuticals, Inc.
BU
Furiex Pharmaceuticals : Announces First Quarter 2014 Earnings Release and Conference Call
BU
Furiex Pharmaceuticals : Announces Acceptance to Late-Breaking Abstract Session at Digestive Disease Week 2014
BU
Furiex Pharmaceuticals : Confirms Takeda Will Present Additional Data from the EXAMINE Trial at the American College of Cardiology's 63rd Annual Scientific Session
PU
Furiex Pharmaceuticals : Confirms Takeda Will Present Additional Data from the EXAMINE Trial at the American College of Cardiology’s 63rd Annual Scientific Session
BU
Furiex Pharmaceuticals Inc : Furiex Pharmaceuticals Reports Fourth Quarter and Full-Year 2013 Financial Results
BU
Furiex Pharmaceuticals Inc : Furiex Pharmaceuticals Confirms Takeda's Submission of a New Drug Application for Trelagliptin Succinate (SYR-472) in Japan for the Treatment of Type 2 Diabetes
BU
Furiex Pharmaceuticals Inc : Furiex Pharmaceuticals Announces Fourth Quarter 2013 Earnings Release and Conference Call
BU
Furiex Pharmaceuticals Inc : Furiex Pharmaceuticals Announces Positive Top-Line Results of Two Pivotal Phase III Clinical Trials of Eluxadoline in Patients with IBS-d
BU
Furiex Pharmaceuticals Inc : Furiex Reports Third Quarter 2013 Financial Results
BU
Furiex Pharmaceuticals Inc : Furiex Pharmaceuticals Announces Priligy® Launch in the United Kingdom by Menarini
BU
Furiex Pharmaceuticals Inc : Furiex Pharmaceuticals Announces Management Changes
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Furiex Pharmaceuticals Inc